| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.001 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |